A bill to provide that no funds may be expended by the United States Trade Representative to negotiate data exclusivity provisions for certain pharmaceutical products.

referredUnited States· United States Congress· EN

Introduced

8 October 2004

Last action

—

Status

Read twice and referred to the Committee on Finance. (text of measure as introduced: CR S10848)

Summary

Prohibits funds appropriated or otherwise obligated to the U.S. Trade Representative from being expended to negotiate data exclusivity provisions with any country with respect to public health pharmaceutical products or to require actions of another country which interfere with a country's access to such products.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

3 official files

Introduced in Senate (text)
Introduced in Senate · EN · 8 October 2004
View Download Open at official source
Introduced in Senate (PDF)
Introduced in Senate · EN · 8 October 2004
View Download Open at official source
Introduced in Senate
summary · EN · 8 October 2004
Open at official source

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.

Official source: https://www.congress.gov/bill/108th-congress/senate-bill/2944
Open data entity: https://api.congress.gov/v3/bill/108/s/2944